Literature DB >> 1317760

Central bradykininergic system in normotensive and hypertensive rats.

A L Alvarez1, A Delorenzi, D Santajuliana, S Finkielman, V E Nahmod, C J Pirola.   

Abstract

1. The kinin antagonist des-Arg9-[Leu8]bradykinin, injected into the lateral ventricle, caused a long-lasting, dose-dependent reduction in arterial blood pressure and heart rate in spontaneously hypertensive rats but not in normotensive Wistar-Kyoto rats; the antagonist also blocked the pressor response to ventricularly infused bradykinin in both strains. 2. Bradykinin content was increased in the hypothalamus and septum and decreased in the dorsal medulla of spontaneously hypertensive rats when compared with those of normotensive Wistar-Kyoto rats, whereas similar bradykinin contents were observed in the pineal gland, hypophysis and rostroventrolateral medulla of both rat strains. 3. Increased concentrations of bradykinin and its precursor kininogen were found in the cerebrospinal fluid of spontaneously hypertensive rats. 4. Bradykinin receptor numbers, measured as the binding of [125I-Tyr1]bradykinin to nervous tissue, were found to be increased in the dorsal medulla and hypophysis, and to be decreased in the pineal gland, of spontaneously hypertensive rats. 5. Therefore, the central kinin system may participate, by both pre- and post-synaptic mechanisms, in the maintenance of hypertension in spontaneously hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317760     DOI: 10.1042/cs0820513

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

Review 1.  Pharmacological blood-brain barrier modification for selective drug delivery.

Authors:  T F Cloughesy; K L Black
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

2.  The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats.

Authors:  C Emanueli; J Chao; D Regoli; L Chao; A Ni; P Madeddu
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

3.  Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats.

Authors:  Frank Cloutier; Hudson de Sousa Buck; Brice Ongali; Réjean Couture
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 4.  Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases.

Authors:  Menglong Wang; Wei Pan; Yao Xu; Jishou Zhang; Jun Wan; Hong Jiang
Journal:  J Inflamm Res       Date:  2022-05-25

5.  Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.

Authors:  Frank Cloutier; Brice Ongali; Maria M Campos; Gaétan Thibault; Witold Neugebauer; Réjean Couture
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

6.  Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms.

Authors:  Srinivas Sriramula; Eric Lazartigues
Journal:  Hypertension       Date:  2017-10-16       Impact factor: 10.190

7.  An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies.

Authors:  Graziela S Ceravolo; Augusto C Montezano; Maria T Jordão; Eliana H Akamine; Tiago J Costa; Ana P Takano; Denise C Fernandes; Maria L Barreto-Chaves; Francisco R Laurindo; Rita C Tostes; Zuleica B Fortes; Renato P Chopard; Rhian M Touyz; Maria Helena C Carvalho
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

8.  Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect.

Authors:  Takuto Nakamura; Masanobu Yamazato; Akio Ishida; Yusuke Ohya
Journal:  Int J Hypertens       Date:  2017-03-22       Impact factor: 2.420

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.